Mylo

Mylo

Mylo has been developed as a non-medicated anti-diarrhoeal probiotic and was approved for commercialisation in New Zealand, from mid-2017. The product is designed to improve health and vitality of young animals, enhancing growth and development for improved productivity in maturity.

Sales have commenced in Australia and New Zealand and applications are being prepared for commercialisation in other international markets.